AQP4 and myeloid sarcoma: Disease-specific correlations between BA profiles and Expanded Disability Status Scale scores were also observed.<h4>Conclusions</h4>Serum bile acid metabolomic profiling reveals disease- and subtype-specific signatures that may assist in the differential diagnosis of NMOSD and MS, particularly in AQP4-IgG-seronegative cases.